[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336348-105":3,"doc-detail-336348-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ythdc1-dependent-m6a-modification-modulated-foxm1-promotes-glycolysis-and-tumor-progression-through-cenpa-in-triple-negative-breast-cancer","YTHDC1-dependent m6A modification modulated FOXM1 promotes glycolysis and tumor progression through CENPA in triple-negative breast cancer","","Triple-negative breast cancer (TNBC) is more aggressive than other breast cancer subtypes, with earlier relapse, higher risk of distant metastasis, and poorer prognosis. The study identifies FOXM1 as significantly elevated in TNBC versus other subtypes and normal tissues. FOXM1 knockdown reduces TNBC proliferation and metastasis in vitro and in vivo, while CENPA overexpression restores these effects. YTHDC1-dependent m6A modification modulates FOXM1 and links to glycolysis through the FOXM1/CENPA axis, supporting a potential mechanistic target in TNBC.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ythdc1-dependent-m6a-modification-modulated-foxm1-promotes-glycolysis-and-tumor-progression-through-cenpa-in-triple-negative-breast-cancer/336348/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ythdc1-dependent-m6a-modification-modulated-foxm1-promotes-glycolysis-and-tumor-progression-through-cenpa-in-triple-negative-breast-cancer/336348.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What makes TNBC particularly aggressive in this study?","Question",{"text":63,"@type":64},"TNBC shows heightened aggressiveness with earlier relapse, higher distant metastasis risk, and a worse overall prognosis than other breast cancer subtypes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does FOXM1 affect TNBC growth and metastasis?",{"text":68,"@type":64},"FOXM1 expression is higher in TNBC, and knocking down FOXM1 reduces TNBC proliferation and metastasis in both in vivo and in vitro settings.",{"name":70,"@type":61,"acceptedAnswer":71},"What role do CENPA and YTHDC1-dependent m6A modification play?",{"text":72,"@type":64},"FOX M1-associated effects on CENPA expression and glycolysis are recovered by CENPA overexpression. YTHDC1-dependent m6A modification regulates FOXM1 expression, and inhibiting m6A reverses the increase in FOXM1.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336348,1790869814,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819",8,"Received: 15 August 2023 | Revised: 3 February 2024 | Accepted: 20 February 2024  \nDOI: 10. 1111/cas.16137  \nOR I G I NAL ART I C L E  \nYTHDC1-dependent m6A modification modulated FOXM1 promotes glycolysis and tumor progression through CENPA in triple-negative breast cancer  \nXi Shen1  | Jianxin Zhong4  | Pan Yu5 | Feng Liu6  | Haoran Peng7  | Nianyong Chen2,3   \n1Department of Oncology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China  \n2Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China 3 Division of Head & Neck Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, China  \n4Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China 5Department of Health Management, The Second Hospital Affiliated to Chongqing Medical University, Chongqing, China 6Department of Thyroid and Breast Surgery, Wuhan Fourth Hospital, Wuhan, China  \n7Department of Stomatology, Shenzhen Hospital, University of Chinese Academy of Sciences, Shenzhen, China  \nCorrespondence  \nNianyong Chen, Department of Head and Neck Oncology and Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.  \nEmail: [n_ychen@hotmail.com](n_ychen@hotmail.com)  \nAbstract  \nTriple-negative breast cancer (TNBC) exhibits heightened aggressiveness compared with other breast cancer (BC) subtypes, with earlier relapse, a higher risk of distant metastasis, and a worse prognosis. Transcription factors play a pivotal role in various cancers. Here, we found that factor forkhead box M1 (FOXM1) expression was significantly higher in TNBC than in other BC subtypes and normal tissues. Combining the findings of Gene Ontology (GO) enrichment analysis and a series of experiments, we found that knockdown of the FOXM1 gene attenuated the ability of TNBC cells to proliferate and metastasize both in vivo and in vitro. In addition, Spearman's test showed that FOXM1 significantly correlated with glycolysis-related genes, especially centromere protein A (CENPA) in datasets (GSE76250, GSE76124, GSE206912, and GSE103091) . The effect of silencing FOXM1 on the inhibition of CENPA expression, TNBC proliferation, migration, and glycolysis could be recovered by overexpression of CENPA. According to MeRIP, the level of m6A modification on FOMX1 decreased in cells treated with cycloleucine (a m6A inhibitor) compared with that in the control group. The increase in FOXM1 expression caused by YTHDC1 overexpression could be reversed by the m6A inhibitor, which indicated that YTHDC1 enhanced FOXM1 expression depending on m6A modification. Therefore, we concluded that the YTHDC1-m6A modification/FOXM1/CENPA axis plays an important role in TNBC progression and glycolysis.  \nK E Y WO R D S  \nCENPA, FOXM1 transcription factor, glycolysis, TNBC, YTHDC1-dependent m6A modification  \nAbbreviations: BC, breast cancer; CENPA, centromere protein A; FOXM1, forkhead box M1; GO, Gene Ontology; m6A, N6-methyladenosine; TFs, transcription factors; TNBC, triple-negative breast cancer.  \nXi Shen and Jianxin Zhong contributed equally to this work.  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.  \n© 2024 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.  \n1 | INTRODUCTION  \nBreast cancer is the most common cancer among women and can be classified into three major subtypes: luminal-like, HER2-positive, and TNBC.1 TNBC accounts for approximately 15%–20% of all BC cases and exhibits heightened aggressiveness compared with other BC subtypes, ","cbCail0cSSNOyYYg","https://ap.wps.com/l/cbCail0cSSNOyYYg","pdf",19178140,15,"English","# Abstract\n## Introduction","[{\"question\":\"What makes TNBC particularly aggressive in this study?\",\"answer\":\"TNBC shows heightened aggressiveness with earlier relapse, higher distant metastasis risk, and a worse overall prognosis than other breast cancer subtypes.\"},{\"question\":\"How does FOXM1 affect TNBC growth and metastasis?\",\"answer\":\"FOXM1 expression is higher in TNBC, and knocking down FOXM1 reduces TNBC proliferation and metastasis in both in vivo and in vitro settings.\"},{\"question\":\"What role do CENPA and YTHDC1-dependent m6A modification play?\",\"answer\":\"FOX M1-associated effects on CENPA expression and glycolysis are recovered by CENPA overexpression. YTHDC1-dependent m6A modification regulates FOXM1 expression, and inhibiting m6A reverses the increase in FOXM1.\"}]","YTHDC1-dependent m6A modification modulated FOXM1 promotes glycolysis and tumor progression through CENPA in triple-negative breast cancer | PDF",1790014656,38,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e77e7edb4b092cb4b92312091393bdd.webp",983,1291,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73b7085156e8f0af64f13c161cb10896.webp",982,1290,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5642476dae441d2266d5074b933536ac.webp",981,1289,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/37d2bd8c15a1b2e8ff60261e15b6fbb8.webp",980,1287,{"code":4,"msg":82,"data":117},[118,122,126,130,135,139,144,147,152,155,159],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":136,"show_sort_weight":137,"slug":138},"Technology",50,"technology",{"id":140,"doc_module":4,"doc_module_name":25,"category_name":141,"show_sort_weight":142,"slug":143},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":145,"slug":146},30,"research-report",{"id":148,"doc_module":4,"doc_module_name":25,"category_name":149,"show_sort_weight":150,"slug":151},9,"Religion & Spirituality",20,"religion-spirituality",{"id":150,"doc_module":4,"doc_module_name":25,"category_name":153,"show_sort_weight":150,"slug":154},"World Cup","world-cup",{"id":156,"doc_module":4,"doc_module_name":25,"category_name":157,"show_sort_weight":156,"slug":158},10,"Lifestyle","lifestyle",{"id":160,"doc_module":4,"doc_module_name":25,"category_name":161,"show_sort_weight":131,"slug":162},19,"General","general"]